Clinical trial
A Non-Inferiority Comparison of Fluviral™ Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone®) in Adults ≥ 50 Years Old Living in the Community
NCT00232947 is registered in ClinicalTrials.gov with ID Biomedical Corporation, Quebec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-Inferiority Comparison of Fluviral™ Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone®) in Adults ≥ 50 Years Old Living in the Community
- Lead sponsor
- ID Biomedical Corporation, Quebec
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- February 28, 2006
- Enrollment
- 900
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
influenza